Eye Infection (Pseudomonas aeruginosa)
Overview
Plain-Language Overview
Eye Infection (Pseudomonas aeruginosa) is a serious infection that affects the eye, particularly the cornea, which is the clear front part of the eye. This infection is caused by the bacteria Pseudomonas aeruginosa, which can rapidly damage the eye tissue. It often leads to symptoms such as redness, pain, blurred vision, and discharge from the eye. The infection can threaten vision if not treated promptly because it can cause a corneal ulcer or scarring. People who wear contact lenses or have eye injuries are at higher risk. The infection primarily affects the ocular surface and can spread quickly, making early recognition important.
Clinical Definition
Eye Infection (Pseudomonas aeruginosa) is an acute bacterial keratitis characterized by infection of the corneal epithelium and stroma by the gram-negative opportunistic pathogen Pseudomonas aeruginosa. This organism produces proteases and exotoxins that cause rapid corneal tissue destruction and inflammation. The infection is commonly associated with contact lens use, ocular trauma, or immunocompromised states. Clinically, it presents with severe ocular pain, purulent discharge, corneal infiltrates, and hypopyon. The condition is a major cause of corneal ulcers and can lead to permanent vision loss if untreated. Prompt diagnosis and aggressive antimicrobial therapy are critical to prevent complications such as corneal perforation.
Inciting Event
Introduction of bacteria via contaminated contact lenses or lens solutions.
Corneal epithelial injury from trauma or foreign bodies allowing bacterial invasion.
Use of topical corticosteroids that suppress local immunity and facilitate infection.
Latency Period
Symptoms typically develop within 24 to 48 hours after bacterial exposure or corneal injury.
Rapid progression from initial irritation to severe keratitis can occur within 1 to 3 days.
Diagnostic Delay
Early symptoms may mimic viral conjunctivitis or allergic eye disease, leading to misdiagnosis.
Lack of awareness about the severity of contact lens-related keratitis delays presentation.
Initial empirical treatment with inappropriate antibiotics may mask symptoms and delay diagnosis.
Clinical Presentation
Signs & Symptoms
Severe ocular pain and photophobia
Decreased visual acuity due to corneal involvement
Redness and swelling of the conjunctiva and eyelids
Excessive tearing and purulent discharge
Foreign body sensation in the affected eye
History of Present Illness
Rapid onset of severe eye pain, redness, and photophobia within days of exposure.
Progressive decreased visual acuity and excessive tearing.
History of contact lens use or recent ocular trauma preceding symptom onset.
Possible discharge that is purulent or mucopurulent.
Past Medical History
Previous episodes of microbial keratitis or corneal ulcers increase risk of recurrence.
History of ocular surface disease such as dry eye or blepharitis.
Use of topical corticosteroids or immunosuppressive eye drops.
Chronic contact lens wear with poor hygiene practices.
Family History
No significant familial predisposition is typically associated with Pseudomonas aeruginosa eye infections.
Rarely, inherited immune deficiencies may increase susceptibility to severe infections.
Physical Exam Findings
Corneal ulceration with a grayish-white infiltrate and surrounding edema
Conjunctival injection and chemosis indicating inflammation
Purulent discharge from the affected eye
Hypopyon, a layering of white blood cells in the anterior chamber
Corneal epithelial defect visible with fluorescein staining
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by clinical examination revealing a corneal ulcer with surrounding stromal infiltrate and hypopyon. Confirmation requires corneal scraping for Gram stain and culture, which typically shows gram-negative rods consistent with Pseudomonas aeruginosa. The presence of rapid progression, severe pain, and purulent discharge supports the diagnosis. Additional diagnostic tools include fluorescein staining to identify epithelial defects and slit-lamp examination to assess the extent of corneal involvement.
Pathophysiology
Key Mechanisms
Pseudomonas aeruginosa produces exotoxins and proteases that cause rapid corneal tissue destruction.
Biofilm formation on contact lenses or ocular surfaces enhances bacterial persistence and resistance to treatment.
Flagella and pili facilitate bacterial adherence and invasion of corneal epithelium.
Host neutrophilic inflammation leads to corneal edema, ulceration, and potential scarring.
Endotoxin release triggers intense local immune response contributing to tissue damage.
| Involvement | Details |
|---|---|
| Organs | Eye is the organ affected by Pseudomonas aeruginosa infection, presenting with keratitis, pain, redness, and potential vision loss. |
| Tissues | Corneal stroma is the primary site of tissue destruction in Pseudomonas aeruginosa keratitis due to enzymatic degradation. |
Corneal epithelium serves as the initial barrier breached by Pseudomonas during infection. | |
Conjunctival tissue becomes inflamed and contributes to ocular redness and discharge. | |
| Cells | Neutrophils are the primary immune cells that infiltrate the cornea to phagocytose Pseudomonas aeruginosa and release enzymes causing tissue damage. |
Corneal epithelial cells act as a physical barrier and participate in innate immune responses by releasing antimicrobial peptides. | |
Macrophages contribute to bacterial clearance and modulate inflammation in the infected corneal tissue. | |
| Chemical Mediators | Interleukin-8 (IL-8) is elevated in infected corneal tissue and recruits neutrophils to the site of Pseudomonas infection. |
Tumor necrosis factor-alpha (TNF-α) promotes inflammation and contributes to corneal tissue damage during infection. | |
Matrix metalloproteinases (MMPs) released by neutrophils degrade corneal extracellular matrix, leading to ulceration. |
Treatments
Pharmacological Treatments
Topical fluoroquinolones (e.g., ciprofloxacin, levofloxacin)
- Mechanism:
Inhibit bacterial DNA gyrase and topoisomerase IV, preventing DNA replication in Pseudomonas aeruginosa.
- Side effects:
Ocular irritation
Allergic reactions
Photosensitivity
- Clinical role:
First-line
Topical aminoglycosides (e.g., tobramycin, gentamicin)
- Mechanism:
Bind to the 30S ribosomal subunit, inhibiting bacterial protein synthesis in Pseudomonas aeruginosa.
- Side effects:
Ocular toxicity
Corneal epithelial damage
Allergic reactions
- Clinical role:
First-line
Systemic antipseudomonal antibiotics (e.g., ceftazidime, piperacillin-tazobactam)
- Mechanism:
Inhibit bacterial cell wall synthesis or protein synthesis to treat severe or systemic Pseudomonas infections.
- Side effects:
Nephrotoxicity
Hypersensitivity reactions
Gastrointestinal upset
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Urgent ophthalmologic evaluation with corneal scraping for culture and sensitivity testing to guide therapy.
Frequent eyelid hygiene and removal of contact lenses to reduce bacterial load and prevent reinfection.
Supportive care including pain management and avoidance of eye rubbing to prevent corneal damage.
Prevention
Pharmacological Prevention
Topical fluoroquinolones for prophylaxis in high-risk contact lens users
Antiseptic eye drops such as povidone-iodine before ocular procedures
Prophylactic antibiotics after corneal trauma or surgery
Non-pharmacological Prevention
Proper contact lens hygiene including regular cleaning and avoiding overnight wear
Avoidance of contaminated water exposure while wearing contact lenses
Prompt treatment of ocular surface injuries to prevent infection
Regular ophthalmologic follow-up for patients with chronic eye conditions
Outcome & Complications
Complications
Corneal perforation leading to endophthalmitis
Permanent vision loss from scarring or ulceration
Secondary glaucoma due to inflammation
Orbital cellulitis from extension of infection
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Eye Infection (Pseudomonas aeruginosa) versus Bacterial Keratitis (Staphylococcus aureus)
Eye Infection (Pseudomonas aeruginosa) | Bacterial Keratitis (Staphylococcus aureus) |
|---|---|
Pseudomonas aeruginosa is a gram-negative rod with distinct virulence factors | Staphylococcus aureus commonly causes gram-positive cocci infections |
Strongly associated with extended contact lens wear and exposure to contaminated water | Often associated with trauma or contact lens use but less frequently linked to extended contact lens wear |
Rapidly progressive corneal ulceration with potential for severe corneal melting | Typically presents with slower onset and less aggressive corneal destruction |
Eye Infection (Pseudomonas aeruginosa) versus Fungal Keratitis (Candida albicans)
Eye Infection (Pseudomonas aeruginosa) | Fungal Keratitis (Candida albicans) |
|---|---|
Pseudomonas aeruginosa is a gram-negative bacterium causing bacterial keratitis | Candida albicans is a yeast causing fungal keratitis |
Acute, rapidly progressive ulcer with purulent discharge | Usually has a more indolent, chronic course with feathery-edged infiltrates |
Positive bacterial culture growing gram-negative rods | Positive fungal culture or KOH prep showing yeast or hyphae |
Eye Infection (Pseudomonas aeruginosa) versus Herpes Simplex Virus (HSV) Keratitis
Eye Infection (Pseudomonas aeruginosa) | Herpes Simplex Virus (HSV) Keratitis |
|---|---|
Caused by Pseudomonas aeruginosa, a gram-negative bacterium | Caused by herpes simplex virus type 1 or 2, a DNA virus |
Typically a single acute episode with rapidly progressive corneal ulcer | Characterized by recurrent episodes with dendritic corneal ulcers |
Positive bacterial culture for Pseudomonas aeruginosa | Positive PCR or viral culture from corneal scrapings |
Eye Infection (Pseudomonas aeruginosa) versus Acanthamoeba Keratitis
Eye Infection (Pseudomonas aeruginosa) | Acanthamoeba Keratitis |
|---|---|
Also linked to contact lens use but more commonly associated with contaminated lens solutions | Strongly linked to contact lens use with exposure to contaminated water or soil |
Severe pain with rapid corneal destruction and purulent discharge | Pain disproportionate to clinical findings and a chronic, indolent course |
Growth of Pseudomonas aeruginosa on standard bacterial culture media | Detection of cysts or trophozoites on confocal microscopy or culture on non-nutrient agar |